7 things to buy before the December 15th round of tariffs go into effect
If you’re an expecting parent or already have small children, loading up on diapers before Dec. 15th could be a good idea. According to the tariff list, baby diapers of knitted or crocheted cotton, synthetic fibers or textile silk materials will be affected. New or expecting parents will also want to secure high chairs and booster seats before tariffs go into effect.
According to the official list, “Printed cards bearing personal greetings, messages or announcements, with or without envelopes or trimmings,’’ wll face new tariffs. Those who celebrate Christmas will see their tinsel, ornaments and nativity-scene decorations become more expensive after mid-December.Your daily hygiene routine isn’t safe from the tariffs, either, particularly if you have long hair you want to straighten or dry.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
34 Things on Sale You’ll Actually Want to Buy: From Adidas to Le CreusetThe best of the Internet’s sales bins, including a cozy corduroy jumpsuit, some very bold boots, a jaunty neon-green clutch, and a half-off Samsung 4K TV
Lire la suite »
Here are the holiday return policies for 31 popular retailers, including Best Buy, Apple, and AmazonHoliday returns don't have to be hectic. Find everything you need to know about the return policies from 30+ popular retailers, like Amazon and Apple.
Lire la suite »
The Best Holiday Gifts to Buy at Ulta Right NowGet them before they sell out.
Lire la suite »
With U.S. hiring robust, Fed's rate pause gets buy-inA show of strength in the labor market is giving traders a bit more confidence t...
Lire la suite »
17 Buy-Now-Wear-Forever Houndstooth Blazers and CoatsInvest in timeless checks this fall.
Lire la suite »
Amgen to Buy Stake in Chinese Cancer-Drugmaker BeiGeneU.S. pharmaceutical company Amgen said it is buying a roughly 20% stake in a Chinese biotechnology company focused on oncology for $2.7 billion in cash, further demonstrating China’s emergence as a key market for foreign pharmaceutical companies.
Lire la suite »